CAD
EVFM

Craig A. Drill’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Craig A. Drill’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.49M Hold
14,811
– – 6.12% 4
2016
Q2 		$1.31M Buy
+14,811
New +$1.33M 2.57% 8

Other funds holding EVFM

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WAS
WESPAC Advisors SoCal Pasadena, California $560M AUM 37.11% 1-Year Est. Return

Craig A. Drill's EVFM Position: Q3 2016 in Review

Craig A. Drill held its Evofem Biosciences, Inc. Common Stock (EVFM) position steady in Q3 2016 at 14,811 shares worth $1.49M. The position accounts for 6.12% of the portfolio, ranked #4.

Craig A. Drill first reported a position in EVFM in Q2 2016 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold EVFM as of Q3 2016.

  • Craig A. Drill held 14,811 shares of Evofem Biosciences, Inc. Common Stock worth $1.49M as of Q3 2016.
  • Craig A. Drill left its Evofem Biosciences, Inc. Common Stock share count unchanged in Q3 2016.
  • Evofem Biosciences, Inc. Common Stock made up 6.12% of Craig A. Drill's portfolio in Q3 2016, its #4 holding.
  • Craig A. Drill first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2016 and has held it in 2 quarters since.
  • 15 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2016.

Based on Craig A. Drill's 13F filing for Q3 2016, filed 10 Nov 2016.